OR WAIT 15 SECS
PLT Health Solutions Inc., in partnership with Laila Nutraceuticals, is launching a new joint health and muscle recovery ingredient marketed to the active and sports nutrition market, called Dynaleve Muscle+Joint Formula.
PLT Health Solutions Inc. (Morristown, NJ), in partnership with Laila Nutraceuticals, is launching a new joint health and muscle recovery ingredient marketed to the active and sports nutrition market, called Dynaleve Muscle+Joint Formula. The ingredient contains a low dose of Boswellia serrata, delivered in a neutral-tasting, water soluble form.
In an unpublished clinical study, Dynaleve was evaluated using the Delayed Onset Muscle Soreness model. In the trial, 50 recreationally active men were given either 60 mg of Dynaleve or placebo for 10 day, with eccentric exercise intervention at day 7. Results showed that, compared to placebo, daily supplementation with the ingredient reduced muscle soreness by 47%, and knee soreness by 31%. Full recovery of strength was achieved by 96% of subjects in the Dynaleve group on day 3, 2.5 times more than subjects in the placebo group. Subjects taking Dynaleve also saw improvements in biomarkers related to inflammation, muscle damage, and connective tissues damage.
“Dynaleve is such a novel and powerful ingredient in that it that supports both muscle and joint comfort. The new study points to an ingredient that can change the landscape of the active and sports nutrition market by offering a comprehensive, low dose solution to post-exercise recovery, while promoting the ability to perform at a higher level with less recovery time,” said Seth Flowerman, president and CEO of PLT Health Solutions, in a press release. “At the same time, this study highlights the potential for Dynaleve to help people feel better faster in their day to day lives – things like climbing stairs or walking with less stiffness can be made easier.”
“Dynaleve was specifically developed as a low-dose, neutral-tasting, and soluble solution for ease of incorporation into a broad range of applications and delivery systems,” added Flowerman. “This solution represents a significant invention in its own right as it overcomes the traditional challenges of incorporating Boswellia serrata into organoleptically sensitive and water-soluble formulations.”